2007

1. Rink L, Slupianek A, Stoklosa T, Nieborowska-Skorska M, Urbanska K, Seferynska I, Reiss K, Skorski T. Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex RAD50-Mre11-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells. Blood. 2007 Apr 12; [Epub ahead of print]

2. Issat T, Nowis D, Legat M, Makowski M, Klejman MP, Urbański J, Skierski J, Koronkiewicz M, Stokłosa T, Brzezińska A, Bil J, Gietka J, Jakóbisiak M, Gołąb J. Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo. International Journal of Oncology 2007, 30(6):1413-25

3. Bil J., Winiarska M.. Molekularne mechanizmy aktywności terapeutycznej rytuksymabu – przeciwciała monoklonalnego anty-CD20 Postępy biologii komórki 2007; Tom 34, NR 2 (335-359)

4. Kocanova S, Buytaert E, Matroule JY, Piette J, Golab J, de Witte P, Agostinis P. Induction of heme-oxygenase 1 requires the p38(MAPK) and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy. Apoptosis. 2007;12(4):731-41.